ARIX BIOSCIENCE PLC
Director/PDMR Shareholding
LONDON, 13 March 2020: Arix Bioscience plc (LSE:ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces a conditional share award to Jonathan Peacock, Chairman, relating to his service in 2019 as an Executive Director. The award is subject to performance conditions over a three year assessment period, consistent with the awards made to other Executive Directors in 2019, as detailed on page 70 of the Annual Report and Accounts.
| PDMR DEALING NOTIFICATION |
| Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them |
| 1 |
Details of the person discharging managerial responsibilities / person closely associated |
| a) |
Name |
Jonathan Peacock |
| 2 |
Reason for the notification |
| a) |
Position / status |
Chairman |
| b) |
Initial notification /
Amendment |
Initial Notification |
| 3 |
Details of issuer |
| a) |
Name |
Arix Bioscience plc |
| b) |
LEI |
213800OVT3AHQCXNIX43 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of Arix Bioscience plc |
| Identification code |
GB00BD045071 |
| b) |
Nature of the transaction |
Conditional share award |
| c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
| Nil |
231,348 |
| d) |
Aggregated information |
Aggregated price |
Aggregated volume |
| N/A (single transaction) |
N/A (single transaction) |
| e) |
Date of the transaction |
12 March 2020 |
| f) |
Place of the transaction |
Outside a trading venue |
For further information:
Robert Lyne Chief Operating Officer and General Counsel +44 (0)207 290 1050
- Ends -